• Exvastat logo thumbnail

    Exvastat Enters COVID-19 Arena With Intravenous Imatinib

  • DNA strand

    Inivata announces strategic collaboration and investment from NeoGenomics

  • PetMedix

    PetMedix secures investment from CIC to fund next stage of growth

  • BioMed campus Babaraham

    PetMedix demonstrates ability to raise critical investment at a time of uncertainty

  • Imagen tech

    Imagen recognised by SIIA as Best Content Management Platform

  • Sense_Diagnostic Test for COVID-19_SQUARE

    Sense reported on CBS Weekend News

  • Exvastat logo thumbnail

    Exvastat receives prestigious Innovative Medicines Initiative grant to fund clinical study of imatinib in the treatment of COVID-19-associated ARDS

  • Riverlane Team square

    Consortium led by Riverlane awarded £7.6M grant from the Industrial Challenge Strategy Fund

  • Sense_Diagnostic Test for COVID-19_SQUARE

    Phillips-Medisize is helping Sense Biodetection produce a first-of-its-kind molecular diagnostic test

  • Blood test square

    Inivata launches RaDaR™ for the detection of residual disease and recurrence

  • Sense_Diagnostic Test for COVID-19_SQUARE

    Instrument-Free POC Molecular Coronavirus Test Being Developed by Sense

  • Sense_Diagnostic Test for COVID-19_SQUARE

    SPOTLIGHT ON: COVID-19 Testing - Insights into some whats and whys

  • Sense_Diagnostic Test for COVID-19_SQUARE

    Sense Accelerates Instrument-Free Molecular Diagnostic Test for COVID-19

  • Cancer cells

    Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation

  • Bicycle Technology

    Bicycle will receive a $30 million upfront payment; upfront payment and potential discovery, development, regulatory and commercial milestones could total up to $1.7 billion

  • CMR Surgical square

    Versius® , a next-generation Surgical Robotic System has received TGA Approval in Australia following a successful launch into the NHS.